Showing results (141-150 of 377) with videos related to
Sort By:
Pageof 38
Cell Cycle (Georgetown, Tex.)|October 23, 2012
Ketone body utilization drives tumor growth and metastasisUbaldo E Martinez-Outschoorn, Zhao Lin, Diana Whitaker-Menezes, et al.BMC Cancer|May 30, 2021
Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?Lorna McWilliams, Victoria G Woof, Louise S Donnelly, et al.Cancer Treatment Reviews|July 22, 2011
Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic reviewJavaid Iqbal, Ophira M Ginsburg, Thiwanka D Wijeratne, et al.Cancers|October 14, 2022
Implementing Risk-Stratified Breast Screening in England: An Agenda Setting MeetingLorna McWilliams, D Gareth Evans, Katherine Payne, et al.BMC Medical Informatics and Decision Making|October 3, 2014
Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?Mattia C F Prosperi, Sarah L Ingham, Anthony Howell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trialAlistair Ring, Ivana Sestak, Michael Baum, et al.Hereditary Cancer in Clinical Practice|January 27, 2018
Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindredsMev Dominguez-Valentin, D Gareth R Evans, Sigve Nakken, et al.Breast Cancer Research : BCR|April 6, 2012
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC studyKatja Lundgren, Matthew Brown, Silvia Pineda, et al.Journal of Medical Genetics|March 30, 2013
Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2Sarah Louise Ingham, Jane Warwick, Iain Buchan, et al.Oncogene|March 16, 2002
Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancerTimothy R Porter, Frances M Richards, Richard S Houlston, et al.Pageof 38